Kidney Transplant: Autologous Tolerogenic Dendritic Cells

We are testing a new treatment using patients' own immune cells to help highly sensitized kidney transplant recipients accept their new organ. This study aims to improve transplant success rates for these individuals.

>2 yearsSafety phase (I)NephrologyUrology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Hospital Germans Trias I Pujol
KIDNEY AND PANCREAS TRASPLANT UNIT
Badalona, Spain
Hospital Del Mar
Nephrology
Barcelona, Spain
Hospital Universitari Vall D Hebron
Nephrology
Barcelona, Spain

Sponsor: Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.